Higher doses may increase the likelihood of gastrointestinal events, but patients are typically better adapted to tolerability by the time they reach those doses
Laverman r eceived lecture fees from Sanofi, AstraZeneca and Janssen and has served as a consultant for AbbVie, Sanofi, Novo Nordisk , AstraZeneca, Boehringer Ingelheim and Merck Sharp & Dohme Annemarie van der Aart-van der Beek reports no conflicts of interest Klaas Hoogenberg reports no conflicts of interest Andr P
Start with what your body and clinician allow: bodyweight movements, resistance bands, light dumbbells, machines, or a supervised plan if you need support
The search strategy was constructed using a combination of keywords and Medical Subject Headings (MeSH), including terms such as Papillary Thyroid Cancer, Thyroid Neoplasms, DPP-IV inhibitors, SGLT2 inhibitors, and their variations